View Older Stories View More Recent Stories

Nov 14, 2022 12:16PM Form 13F-NT LADENBURG THALMANN ASSET For: Sep 30
Nov 14, 2022 07:30AM Zynerba Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Highlights
Nov 14, 2022 07:30AM Zynerba Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Highlights
Nov 14, 2022 07:30AM Windtree Therapeutics Reports Third Quarter 2022 Financial Results and Provides Key Business Updates
Nov 11, 2022 03:08PM Modiv Announces Initiation of Equity Analyst Coverage by Ladenburg Thalmann with a “Buy” Recommendation
Nov 11, 2022 09:01AM UPDATE: Ladenburg Thalmann Starts Modiv (MDV) at Buy
Nov 9, 2022 09:00AM Data I/O to Present at Upcoming Investor Conferences
Nov 8, 2022 04:05PM NEUROBO ANNOUNCES CLOSING OF $32.3 MILLION UNDERWRITTEN PUBLIC OFFERING INCLUDING FULL EXERCISE OF OVERALLOTMENT OPTION AND CONCURRENT PRIVATE PLACEMENT
Nov 4, 2022 09:16AM NeuroBo Pharmaceuticals (NRBO) Announces Pricing Of $30 Million Underwritten Public Offering And Concurrent Private Placement
Nov 4, 2022 09:15AM NEUROBO ANNOUNCES PRICING OF $30 MILLION UNDERWRITTEN PUBLIC OFFERING AND CONCURRENT PRIVATE PLACEMENT
Nov 4, 2022 06:44AM UPDATE: Ladenburg Thalmann Starts Peak Bio (PKBO) at Buy, PT $15
Nov 3, 2022 04:30PM Vallon Pharmaceuticals Reports Third Quarter 2022 Financial Results
Nov 3, 2022 04:30PM Vallon Pharmaceuticals Reports Third Quarter 2022 Financial Results
Nov 3, 2022 10:59AM New York Mortgage Trust (NYMT) PT Lowered to $3 at Ladenburg Thalmann
Nov 1, 2022 07:00AM Bitfarms Provides October 2022 Production and Mining Operations Update
Nov 1, 2022 07:00AM Bitfarms Provides October 2022 Production and Mining Operations Update
Oct 28, 2022 04:16PM Arca Biopharma (ABIO) Reports Q3 Net Loss of $2.3M, Cash Position of $43.9M
Oct 28, 2022 04:15PM ARCA biopharma Announces Third Quarter 2022 Financial Results
Oct 19, 2022 05:32PM Saratoga Investment Corp. Prices Public Offering of $40.0 Million 8.00% Notes Due 2027
Oct 19, 2022 05:32PM Saratoga Investment Corp. Prices Public Offering of $40.0 Million 8.00% Notes Due 2027
Oct 19, 2022 08:08AM Saratoga Investment Corp. Announces Offering of Notes and BBB+ Investment Grade Rating from Egan-Jones Ratings Company
Oct 19, 2022 08:08AM Saratoga Investment Corp. Announces Offering of Notes and BBB+ Investment Grade Rating from Egan-Jones Ratings Company
Oct 18, 2022 04:15PM Nuwellis Announces Closing of $11.04 Million Underwritten Public Offering Including Full Exercise of Overallotment Option
Oct 17, 2022 04:11PM Ra Medical Systems (RMED) Raises $7.6 Million Through Completed At-The-Market Facility
Oct 17, 2022 04:05PM Ra Medical Systems Raises $7.6 Million Through Completed At-The-Market Facility
Oct 17, 2022 10:16AM Wall Street surges as market seeks bottoming signs
Oct 14, 2022 08:31AM Nuwellis (NUWE) Prices Upsized $9.6M Offering at $0.25/sh
Oct 14, 2022 08:30AM Nuwellis Announces Pricing of $9.6 Million Upsized Underwritten Public Offering
Oct 7, 2022 07:01AM Ladenburg Thalmann Starts Corvus Pharmaceuticals (CRVS) at Buy
Oct 4, 2022 04:05PM Saratoga Investment Corp. Announces Fiscal Second Quarter 2023 Financial Results
Oct 4, 2022 09:06AM GBS Inc. (GBS) Acquires Intelligent Fingerprinting Limited
Oct 4, 2022 09:05AM GBS Inc. Acquires Intelligent Fingerprinting Limited and its Proprietary Drugs of Abuse Screening Technology
Sep 30, 2022 06:26AM Qomolangma Acquisition Corp. (QOMO) IPO Prices at $10
Sep 29, 2022 07:35PM Qomolangma Acquisition Corp. Announces Pricing of $50 Million Initial Public Offering
Sep 29, 2022 07:35PM Qomolangma Acquisition Corp. Announces Pricing of $50 Million Initial Public Offering
Sep 29, 2022 01:31PM Palatin to Participate in Ladenburg Thalmann Healthcare Conference
Sep 29, 2022 07:30AM Annovis Bio to Present at the 2022 Ladenburg Thalmann Healthcare Conference
Sep 29, 2022 05:45AM Wall Street ends down sharply; investors fret over economy
Sep 27, 2022 08:00AM Ovid Therapeutics to Present at the Ladenburg Thalmann 2022 Healthcare Conference
Sep 27, 2022 08:00AM Ovid Therapeutics to Present at the Ladenburg Thalmann 2022 Healthcare Conference
Sep 26, 2022 08:00AM Immutep to Participate in Two Upcoming Investor Conferences
Sep 23, 2022 06:50AM NovaBay Pharmaceuticals to Present at the Ladenburg Thalmann 2022 Healthcare Conference
Sep 22, 2022 04:10PM Lipocine to Present at Ladenburg Thalmann 2022 Healthcare Conference
Sep 22, 2022 04:05PM Eledon Pharmaceuticals to Present at Ladenburg Thalmann Healthcare Conference
Sep 22, 2022 04:05PM Eledon Pharmaceuticals to Present at Ladenburg Thalmann Healthcare Conference
Sep 22, 2022 09:00AM Artelo Biosciences to Present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29th
Sep 22, 2022 08:30AM Vericel to Present at the Ladenburg Thalmann Healthcare Conference
Sep 22, 2022 08:30AM Vericel to Present at the Ladenburg Thalmann Healthcare Conference
Sep 22, 2022 08:30AM Checkpoint Therapeutics to Participate in Two Upcoming Investor Conferences
Sep 22, 2022 08:30AM Jaguar Health to Present at Lytham Partners Fall 2022 Investor Conference on September 28th and at Ladenburg Thalmann 2022 Healthcare Conference on September 29th
View More Recent Stories View Older Stories